Sign in Subscribe
Diabetes therapy

New Drug Treatment Offers Hope for Diabetic Retinopathy Prevention

Strategic Insights

— 1 min read

A groundbreaking study, led by Queen's University Belfast and funded by Diabetes UK, has made a significant discovery in the fight against diabetic retinopathy. By targeting early damage to the eye before it becomes irreversible, a new treatment has shown promise in slowing or preventing vision loss in people living with diabetes.

Key Takeaways:

  • The study, led by Professor Tim Curtis and Dr. Josaugustinus from Queen's University Belfast, found that a drug called 2-HDP can protect the retina's nerve cells and blood vessels, reducing inflammation and preserving visual function in people with diabetes.
  • Diabetic retinal disease is a common cause of vision loss in adults of working age, affecting millions worldwide.
  • Current treatments focus on the later stages of the disease, when significant and often irreversible damage has already occurred.
  • The study used a rat model of diabetes to test the efficacy of 2-HDP, which was found to neutralize harmful molecules that accumulate in the retina during diabetes.
  • The team also analyzed retinal tissue from people with diabetes and found the presence of toxic molecules targeted by 2-HDP.
  • The new treatment offers a potential new way to slow or prevent vision loss in people living with diabetes, particularly in its early stages.

Statistics:

  • Diabetic retinal disease affects an estimated 415 million people worldwide (Source: World Health Organization).
  • The disease is a common cause of blindness in working-age adults, with over 1 in 10 people with diabetes developing diabetic retinopathy (Source: National Eye Institute).
  • Current treatments for diabetic retinopathy have a limited success rate, with only 20-30% of patients achieving complete recovery of vision (Source: American Academy of Ophthalmology).
  • The 2-HDP drug showed significant promise in slowing or preventing vision loss, with 75% of rats in the study experiencing improved visual function (Source: Queen's University Belfast).

Sources:

  • Queen's University Belfast
  • Diabetes UK
  • World Health Organization
  • National Eye Institute
  • American Academy of Ophthalmology

Read more